F2-isoprostanes are correlated with trans fatty acids in the plasma of pregnant women

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 91, Issue 6, 2014, Pages 243-249

  Larose, Jessica ^a   Julien, Pierre ^a,b   Greffard, Karine ^a,b   Fraser, William D ^c   Audibert, Francois ^c   Wei, Shu Qin ^c   Bilodeau, Jean François ^a,b  

^a University Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

8 iso PGF2 ; Elaidic acid; Mass spectrometry; Oxidative stress; Pregnancy; Vaccenic acid

Indexed keywords

ELAIDIC ACID; ISOPROSTANE DERIVATIVE; PHOSPHOLIPID; TRANS FATTY ACID;

ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FIRST TRIMESTER PREGNANCY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; ISOMERIZATION; LIPID OXIDATION; LIPID PEROXIDATION; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; OXIDATIVE STRESS; PREGNANCY; PREGNANT WOMAN; PROSTAGLANDIN BLOOD LEVEL; THIRD TRIMESTER PREGNANCY; ADOLESCENT; ADULT; BLOOD; GESTATIONAL AGE; ISOMERISM; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; F2-ISOPROSTANES; FEMALE; GESTATIONAL AGE; HUMANS; HYDROLYSIS; ISOMERISM; LIPID PEROXIDATION; LIQUID-LIQUID EXTRACTION; OXIDATIVE STRESS; PREGNANCY; TANDEM MASS SPECTROMETRY; TRANS FATTY ACIDS;

EID: 84921968404     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2014.09.010     Document Type: Article

References (56)

1. List G.R., Kritchevsky D., Ratnayake W.M.N. Trans Fats in Foods 2007, 97-126. AOCS Press, Urbana, IL, USA.
2. Wolff R., Combe N., Destaillats F., Boué C., Precht D., Molkentin J., Entressangles B. Follow-up of the δ4 to δ16 trans-18:1 isomer profile and content in French processed foods containing partially hydrogenated vegetable oils during the period 1995-1999. Anal. Nutr. Implic. Lipids 2000, 35:815-825.
3. Mendis S., Cruz-Hernandez C., Ratnayake W.M. Fatty acid profile of Canadian dairy products with special attention to the trans-octadecenoic acid and conjugated linoleic acid isomers. J. AOAC Int. 2008, 91:811-819.
4. Micha R., Mozaffarian D. Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat. Rev. Endocrinol. 2009, 5:335-344.
5. Mozaffarian D., Aro A., Willett W.C. Health effects of trans-fatty acids: experimental and observational evidence. Eur. J. Clin. Nutr. 2009, 63(Suppl. 2):S5-S21.
6. Brouwer I.A., Wanders A.J., Katan M.B. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans-a quantitative review. PLoS One 2010, 5:e9434.
7. Mozaffarian D. Trans fatty acids-effects on systemic inflammation and endothelial function. Atheroscler. Suppl. 2006, 7:29-32.
8. Mozaffarian D., Katan M.B., Ascherio A., Stampfer M.J., Willett W.C. Trans fatty acids and cardiovascular disease. N. Engl. J. Med. 2006, 354:1601-1613.
9. Gebauer S.K., Psota T.L., Kris-Etherton P.M. The diversity of health effects of individual trans fatty acid isomers. Lipids 2007, 42:787-799.
10. Lopez-Garcia E., Schulze M.B., Meigs J.B., Manson J.E., Rifai N., Stampfer M.J., Willett W.C., Hu F.B. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr. 2005, 135:562-566.
11. Mozaffarian D., Pischon T., Hankinson S.E., Rifai N., Joshipura K., Willett W.C., Rimm E.B. Dietary intake of trans fatty acids and systemic inflammation in women. Am. J. Clin. Nutr. 2004, 79:606-612.
12. Mihaljevic B., Tartaro I., Ferreri C., Chatgilialoglu C. Linoleic acid peroxidation vs. isomerization: a biomimetic model of free radical reactivity in the presence of thiols. Org. Biomol. Chem. 2011, 9:3541-3548.
13. Ferreri C., Samadi A., Sassatelli F., Landi L., Chatgilialoglu C. Regioselective cis-trans isomerization of arachidonic double bonds by thiyl radicals: the influence of phospholipid supramolecular organization. J. Am. Chem. Soc. 2004, 126:1063-1072.
14. Zghibeh C.M., Raj Gopal V., Poff C.D., Falck J.R., Balazy M. Determination of trans-arachidonic acid isomers in human blood plasma. Anal. Biochem. 2004, 332:137-144.
15. Jiang H., Kruger N., Lahiri D.R., Wang D., Vatele J.M., Balazy M. Nitrogen dioxide induces cis-trans-isomerization of arachidonic acid within cellular phospholipids. Detection of trans-arachidonic acids in vivo. J. Biol. Chem. 1999, 274:16235-16241.
16. Chatgilialoglu C., Ferreri C., Melchiorre M., Sansone A., Torreggiani A. Lipid geometrical isomerism: from chemistry to biology and diagnostics. Chem. Rev. 2014, 114:255-284.
17. Zambonin L., Ferreri C., Cabrini L., Prata C., Chatgilialoglu C., Landi L. Occurrence of trans fatty acids in rats fed a trans-free diet: a free radical-mediated formation?. Free Radic. Biol. Med. 2006, 40:1549-1556.
18. 2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic. Biol. Med. 2011, 50:559-566.
19. 2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 2004, 109:843-848.
20. 2 isoprostanes in hypercholesterolemia. Circulation 1998, 98:2822-2828.
21. 2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chem. Phys. Lipids 2004, 128:165-171.
22. Arcaro G., Fava C., Dagradi R., Faccini G., Gaino S., Degan M., Lechi C., Lechi A., Minuz P. Acute hyperhomocysteinemia induces a reduction in arterial distensibility and compliance. J. Hypertens. 2004, 22:775-781.
23. Schulz E., Gori T., Munzel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens. Res. 2011, 34:665-673.
24. Myatt L., Cui X. Oxidative stress in the placenta. Histochem. Cell Biol. 2004, 122:369-382.
25. Agarwal A., Gupta S., Sharma R.K. Role of oxidative stress in female reproduction. Reprod. Biol. Endocrinol. 2005, 3:28.
26. Morris J.M., Gopaul N.K., Endresen M.J., Knight M., Linton E.A., Dhir S., Anggard E.E., Redman C.W. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br. J. Obstet. Gynaecol. 1998, 105:1195-1199.
27. Siddiqui I.A., Jaleel A., Tamimi W., Al Kadri H.M. Role of oxidative stress in the pathogenesis of preeclampsia. Arch. Gynecol. Obstet. 2010, 282:469-474.
28. 2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid. Redox Signal. 2008, 10:1405-1434.
29. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 1990, 87:9383-9387.
30. 2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J. Biol. Chem. 2006, 281:4616-4623.
31. Milne G.L., Yin H., Hardy K.D., Davies S.S., Roberts L.J. Isoprostane generation and function. Chem. Rev. 2011, 111:5973-5996.
32. Praticò D., Barry O.P., Lawson J.A., Adiyaman M., Hwang S.W., Khanapure S.P., Iuliano L., Rokach J., FitzGerald G.A. IPF2α-I: an index of lipid peroxidation in humans. Proc. Natl. Acad. Sci. 1998, 95:3449-3454.
33. 2-isoprostanes using novel multidimensional solid-phase extraction and LC-MS/MS. J. Lipid Res. 2007, 48:733-744.
34. Basu S. Isoprostanes: novel bioactive products of lipid peroxidation. Free Radic. Res. 2004, 38:105-122.
35. Li H., Lawson J.A., Reilly M., Adiyaman M., Hwang S.W., Rokach J., FitzGerald G.A. Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine. Proc. Natl. Acad. Sci. USA 1999, 96:13381-13386.
36. Smit L.A., Katan M.B., Wanders A.J., Basu S., Brouwer I.A. A high intake of trans fatty acids has little effect on markers of inflammation and oxidative stress in humans. J. Nutr. 2011, 141:1673-1678.
37. Bendsen N.T., Stender S., Szecsi P.B., Pedersen S.B., Basu S., Hellgren L.I., Newman J.W., Larsen T.M., Haugaard S.B., Astrup A. Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women. J. Lipid Res. 2011, 52:1821-1828.
38. Kuhnt K., Wagner A., Kraft J., Basu S., Jahreis G. Dietary supplementation with 11trans- and 12trans-18:1 and oxidative stress in humans. Am. J. Clin. Nutr. 2006, 84:981-988.
39. Turpeinen A.M., Mutanen M., Aro A., Salminen I., Basu S., Palmquist D.L., Griinari J.M. Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am. J. Clin. Nutr. 2002, 76:504-510.
40. Tholstrup T., Raff M., Basu S., Nonboe P., Sejrsen K., Straarup E.M. Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am. J. Clin. Nutr. 2006, 83:237-243.
41. Halliwell B., Lee C.Y. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxid. Redox Signal. 2010, 13:145-156.
42. Mansour M.P., Li D., Sinclair A.J. The occurrence of trans-18:1 isomers in plasma lipids classes in humans. Eur. J. Clin. Nutr. 2001, 55:59-64.
43. Seppanen-Laakso T., Laakso I., Backlund P., Vanhanen H., Viikari J. Elaidic and trans-vaccenic acids in plasma phospholipids as indicators of dietary intake of 18:1 trans-fatty acids. J. Chromatogr. B: Biomed. Appl. 1996, 687:371-378.
44. Shahin A.M., McGuire M.K., Anderson N., Williams J., McGuire M.A. Effects of margarine and butter consumption on distribution of trans-18:1 fatty acid isomers and conjugated linoleic acid in major serum lipid classes in lactating women. Lipids 2006, 41:141-147.
45. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol. 2003, 14:15-19.
46. Wei S.Q., Audibert F., Hidiroglou N., Sarafin K., Julien P., Wu Y., Luo Z.C., Fraser W.D. Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia. BJOG: Int. J. Obstet. Gynaecol. 2012, 119:832-839.
47. 2-isoprostanes in plasma of pregnant women by HPLC-MS/MS using a column packed with core-shell particles. J. Lipid Res. 2013, 54:1505-1511.
48. Counil E., Julien P., Lamarche B., Chateau-Degat M.L., Ferland A., Dewailly E. Association between trans-fatty acids in erythrocytes and pro-atherogenic lipid profiles among Canadian Inuit of Nunavik: possible influences of sex and age. Br. J. Nutr. 2009, 102:766-776.
49. Viviani Anselmi C., Ferreri C., Novelli V., Roncarati R., Bronzini R., Marchese G., Somalvico F., Condorelli G., Montenero A.S., Puca A.A. Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls. J. Interv. Card. Electrophysiol.: Int. J. Arrhythm. Pacing 2010, 27:95-99.
50. Bastani N.E., Gundersen T.E., Blomhoff R. Determination of 8-epi PGF(2alpha) concentrations as a biomarker of oxidative stress using triple-stage liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23:2885-2890.
51. Schwedhelm E., Boger R.H. Application of gas chromatography-mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease. Clin. Chem. Lab. Med. 2003, 41:1552-1561.
52. Hung T.H., Lo L.M., Chiu T.H., Li M.J., Yeh Y.L., Chen S.F., Hsieh T.T. A longitudinal study of oxidative stress and antioxidant status in women with uncomplicated pregnancies throughout gestation. Reprod. Sci. 2010, 17:401-409.
53. Enke U., Jaudszus A., Schleussner E., Seyfarth L., Jahreis G., Kuhnt K. Fatty acid distribution of cord and maternal blood in human pregnancy: special focus on individual trans fatty acids and conjugated linoleic acids. Lipids Health Dis. 2011, 10:247.
54. Sun Q., Ma J., Campos H., Hankinson S.E., Manson J.E., Stampfer M.J., Rexrode K.M., Willett W.C., Hu F.B. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 2007, 115:1858-1865.
55. Zambonin L., Prata C., Cabrini L., Maraldi T., Fiorentini D., Vieceli Dalla Sega F., Hakim G., Landi L. Effect of radical stress and ageing on the occurrence of trans fatty acids in rats fed a trans-free diet. Free Radic. Biol. Med. 2008, 44:594-601.
56. Chatgilialoglu C., Ferreri C. Trans lipids: the free radical path. Acc. Chem. Res. 2005, 38:441-448.